PRODUCT DETAIL

Piperacillin/Tazobactam Kabi 4 g/0,5 g

Code

76541

MA number

15/0317/09-S

Product Form:

plv ifo 10x4 g/0,5 g (liek.inj.skl.)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)

ATC:

J	ANTIINFECTIVES FOR SYSTEMIC USE
J01	ANTIBACTERIALS FOR SYSTEMIC USE
J01C	BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01CR	Combinations of penicillins, incl. beta-lactamase
J01CR05	Piperacillin and enzyme inhibitor

Shelf life:

Container:

glass vial

Route of admin.:

Intravenous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	29.05.2009
Pediatric indication:	Yes
Pediatric posology:	Yes
PIL:	PIL_Piperacillin_Tazobactam Kabi 4g_0,5g_05.2022.pdf
SPC:	SPC_Piperacillin_Tazobactam Kabi 4g_0,5g_05.2022.pdf
Safety feature	Yes
Data update:	14.02.2018